| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/17/2001 | WO2001034819A2 Genes and methods for manipulation of growth |
| 05/17/2001 | WO2001034818A2 Sorghum dwarfing genes and methods of use |
| 05/17/2001 | WO2001034811A2 Bacillus thuringiensis hybrid toxins |
| 05/17/2001 | WO2001034810A2 Genes essential for microbial proliferation |
| 05/17/2001 | WO2001034809A2 Staphylococcus epidermidis nucleic acids and proteins |
| 05/17/2001 | WO2001034808A2 Method of large-scale production and method of testing of the biological activity of a substance from soybean |
| 05/17/2001 | WO2001034807A2 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r¿2? |
| 05/17/2001 | WO2001034806A2 Methods and compositions for screening using diphtheria toxin constructs |
| 05/17/2001 | WO2001034805A2 Human vanilloid receptor gene |
| 05/17/2001 | WO2001034804A1 Human membrane proteins and polynucleotides encoding the same |
| 05/17/2001 | WO2001034803A2 Crib protein zmse1 |
| 05/17/2001 | WO2001034802A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | WO2001034801A2 Recombinant gelatin in vaccines |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034799A1 6 human secreted proteins |
| 05/17/2001 | WO2001034798A1 Cloning and characterization of viral iap associated factor (viaf) in several organisms |
| 05/17/2001 | WO2001034796A1 Chordin-like homologs |
| 05/17/2001 | WO2001034794A1 Casb7434, an antigen over-expressed in colon cancer |
| 05/17/2001 | WO2001034791A2 Chemoreceptors in plant parasitic nematodes |
| 05/17/2001 | WO2001034774A2 Method for protection of mammalian cells by means of over-expressed g-2/m cell cycle coupler |
| 05/17/2001 | WO2001034771A2 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001034770A2 Gene expression modulated by activation of microglia or macrophages |
| 05/17/2001 | WO2001034769A2 24 human secreted proteins |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |
| 05/17/2001 | WO2001034767A2 22 human secreted proteins |
| 05/17/2001 | WO2001034766A2 Protein monitoring the activity of small gtp-binding protein |
| 05/17/2001 | WO2001034654A1 Hedgehog fusion proteins and uses |
| 05/17/2001 | WO2001034653A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | WO2001034648A1 Reduced side-effect hemoglobin compositions |
| 05/17/2001 | WO2001034647A2 Animal collagens and gelatins |
| 05/17/2001 | WO2001034646A2 Recombinant gelatins |
| 05/17/2001 | WO2001034645A2 Mutated il-13 molecules and their uses |
| 05/17/2001 | WO2001034644A1 15 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034642A2 Control of neisserial membrane synthesis |
| 05/17/2001 | WO2001034641A2 Antimicrobial activity of the first cationic cluster of human lactoferrin |
| 05/17/2001 | WO2001034638A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 05/17/2001 | WO2001034636A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | WO2001034635A2 Methods and compositions for peptide synthesis |
| 05/17/2001 | WO2001034634A2 Tumor suppressor molecules and methods of use |
| 05/17/2001 | WO2001034633A2 Methods for treatment of human huntington's disease and methods of screening for active agents |
| 05/17/2001 | WO2001034631A2 PEPTIDE ANALOGS AND MIMETICS SUITABLE FOR IN VIVO USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING INTO AMYLOID, AMYLOID-LIKE DEPOSITS OR β-SHEET RICH PATHOLOGICAL PRECURSOR THEREOF |
| 05/17/2001 | WO2001034630A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034628A1 35 human secreted proteins |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034626A1 28 human secreted proteins |
| 05/17/2001 | WO2001034625A1 Isolation and characterization of human nf-e4 |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034621A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | WO2001034208A1 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 05/17/2001 | WO2001034205A2 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | WO2001034188A1 Malaria vaccine |
| 05/17/2001 | WO2001034186A1 Compositions and methods for modifying an immune response against tropomyosin |
| 05/17/2001 | WO2001034173A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001033977A1 Product and method for control of obesity |
| 05/17/2001 | WO2001033965A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001033964A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001033957A1 Transgenic non-human mammals for monitoring change in calcium ion concentration in cells |
| 05/17/2001 | WO2001033956A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | WO2001033955A1 Animal models for cardiac disease |
| 05/17/2001 | WO2001033954A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | WO2001033945A1 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 05/17/2001 | WO2001033944A1 Compositions and methods for modulation of plant cell division |
| 05/17/2001 | WO2001023577A3 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences |
| 05/17/2001 | WO2001023417A3 Human tumor-associated lak-4p related polynucleotides and polypeptides and their uses |
| 05/17/2001 | WO2001021649A3 Nucleic acids encoding vitamin d response element binding proteins, products related thereto, and methods of using same |
| 05/17/2001 | WO2001019861A3 Apo-2 receptor antibodies |
| 05/17/2001 | WO2001019183A3 Development of an effective gene transfer technique for introducing foreign dna into sperm cells |
| 05/17/2001 | WO2001018043A3 Neurogenic compositions and methods |
| 05/17/2001 | WO2001012598A9 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 05/17/2001 | WO2001011013A3 The interaction of smad6 with hox proteins and uses thereof |
| 05/17/2001 | WO2001009339A3 Moraxella catarrhalis antigen basb117 |
| 05/17/2001 | WO2001009309A3 RESCUE OF MUMPS VIRUS FROM cDNA |
| 05/17/2001 | WO2001007607A3 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | WO2001005427B1 Psca: prostate stem cell antigen and uses thereof |
| 05/17/2001 | WO2001004157A3 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 05/17/2001 | WO2001004142A3 Neurotransmitter transporter |
| 05/17/2001 | WO2000077166A3 Gene expression modulated in gastrointestinal inflammation |
| 05/17/2001 | WO2000071710A3 Expression products of genes involved in diseases related to cholesterol metabolism |
| 05/17/2001 | WO2000070044A3 Human brain t calcium channel alpha-subunit splice variants |
| 05/17/2001 | WO2000066622A9 T20/dp178 and t21/dp107 are activators of human phagocyte formyl peptide receptors |
| 05/17/2001 | WO2000049038A9 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 05/17/2001 | WO2000040613A9 Insulin-like growth factor (igf) i mutant variants |
| 05/17/2001 | WO2000033077A9 Cell matrix plaques of initial bone formation |
| 05/17/2001 | WO2000030671A9 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 05/17/2001 | WO2000030437A9 Transgenic animals |
| 05/17/2001 | WO2000024755A9 Ovary-specific genes and proteins |
| 05/17/2001 | WO2000016609A9 Novel method of regulating seed development in plants and genetic sequences therefor |
| 05/17/2001 | WO1999058562A3 Novel compounds |
| 05/17/2001 | WO1999044620A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/17/2001 | WO1999038972A9 Human genes and gene expression products ii |
| 05/17/2001 | WO1995002040A3 New stromal cell lines from human bone marrow and their use |
| 05/17/2001 | WO1994003601A3 Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan |
| 05/17/2001 | US20010001310 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes |
| 05/17/2001 | US20010001290 Methods for enhancing the production of viral vaccines in cell culture |
| 05/17/2001 | DE19953339A1 Secretinfragmente Secretinfragmente |
| 05/17/2001 | DE19952983A1 Verfahren zum Transfer von molekularen Substanzen mit prokaryontischen nukleinsäurebindenden Proteinen A method for the transfer of molecular substances with prokaryotic nucleic acid binding proteins |
| 05/17/2001 | DE19952982A1 Verfahren zur gerichteten Verpackung von molekularen Substanzen in Proteinhüllen Method for the directed packaging of molecular substances in protein shells |